New online tool aims to ease Family-Building decisions for young cancer survivors
NCT ID NCT06050135
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a web-based decision aid called 'Roadmap to Parenthood' for young women who have completed cancer treatment and are thinking about having children. The tool provides information and planning support to help them make informed choices. Researchers will measure whether it reduces uncertainty and improves quality of life compared to a standard informational booklet.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Roadmap to Parenthood (web-based decision aid and planning tool)
- What this could lead to
- If it works, this tool could help young women who have had cancer feel more confident and less uncertain about their family-building options.
- What could go wrong
- This is a relatively small trial testing a behavioral intervention, so results may not apply to everyone. The tool may not significantly reduce decision uncertainty or improve quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Universtiy
Palo Alto, California, 94305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Smartwatch could spot nerve damage before it starts
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?